Nkarta (NKTX) Free Cash Flow (2019 - 2026)
Nkarta's (NKTX) quarterly Free Cash Flow came in at -$28.6 million in Q1 2026, up 5.04% year-on-year from -$27.2 million in Q1 2025, and down 28.84% quarter-over-quarter from -$22.2 million in Q4 2025.
Nkarta (NKTX) Free Cash Flow (2019 - 2026) Analysis & Trends
Nkarta's Free Cash Flow history runs 8 years deep, the most recent figure standing at -$28.6 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 5.04% year-over-year to -$28.6 million in Q1 2026; TTM through Mar 2026 was -$88.4 million, a 16.26% increase from a year earlier, with the FY2025 full-year figure at -$89.9 million, up 13.64% from the prior year.
- Free Cash Flow slipped to -$28.6 million in Q1 2026 per NKTX's latest filing, from -$22.2 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$18.7 million in Q3 2025 and bottomed at -$42.4 million in Q4 2022.
- The 5-year median for Free Cash Flow is -$25.6 million (2023), against an average of -$25.9 million.
- Across the five-year window, Free Cash Flow plunged 127.0% in 2022 and advanced 28.81% in 2023, its largest moves.
- Year by year, Free Cash Flow stood at -$42.4 million in 2022, then grew by 28.81% to -$30.2 million in 2023, then rose by 14.28% to -$25.9 million in 2024, then rose by 14.11% to -$22.2 million in 2025, then fell by 28.84% to -$28.6 million in 2026.
- Per Business Quant, the three latest NKTX Free Cash Flow figures stand at -$28.6 million (Q1 2026), -$22.2 million (Q4 2025), and -$18.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Nkarta | 170.79 Mn | 170.79 Mn | - | -28.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.61 Mn |
| Mar 31, 2026 | -28.61 Mn |
| Dec 31, 2025 | -22.21 Mn |
| Dec 31, 2025 | -22.21 Mn |
| Sep 30, 2025 | -18.68 Mn |
| Sep 30, 2025 | -18.68 Mn |
| Jun 30, 2025 | -18.89 Mn |
| Jun 30, 2025 | -18.89 Mn |
| Mar 31, 2025 | -30.13 Mn |
| Mar 31, 2025 | -30.13 Mn |
| Dec 31, 2024 | -25.85 Mn |
| Dec 31, 2024 | -25.85 Mn |
| Sep 30, 2024 | -25.32 Mn |
| Sep 30, 2024 | -25.32 Mn |
| Jun 30, 2024 | -24.25 Mn |
| Jun 30, 2024 | -24.25 Mn |
| Mar 31, 2024 | -28.68 Mn |
| Mar 31, 2024 | -28.68 Mn |
| Dec 31, 2023 | -30.16 Mn |
| Dec 31, 2023 | -30.16 Mn |